Contact l Sitemap

home industries issues reasearch weblog press

Home  » Industries » Pharmaceuticals

News Articles : Displaying 46-65 of 161


NIGERIA: Nigeria Adds Fraud Charge Against Pfizer in Civil Lawsuit
by Associated PressWall Street Journal
July 20th, 2007
Nigerian government lawyers added a tougher fraud charge in their $7 billion civil lawsuit against drug maker Pfizer Friday.

US: 3 Executives Spared Prison in OxyContin Case
by Barry MeierThe New York Times
July 20th, 2007
After hearing testimony from parents of young adults who died from overdoses involving the painkiller OxyContin, a federal judge Friday sentenced three top executives of the company that makes the narcotic to three years' probation and 400 hours each of community service in drug treatment programs.

NIGERIA: Pfizer wins early Nigeria battle
BBC News
June 26th, 2007
A Nigerian court has refused to allow more cases to be added to a lawsuit against a pharmaceutical giant accused of improper drugs trials on children.

US: Bristol-Myers to Pay Fine
Agence France Presse
May 31st, 2007
Bristol-Myers Squibb has agreed to plead guilty and pay a $1 million criminal fine for lying to the government about a patent deal on its blood-thinning drug Plavix, officials said Wednesday. The Justice Department said in a statement that the company’s actions had threatened to reduce competition for the drug, one of the best-selling prescription medications worldwide.

NIGERIA: Pfizer Faces Criminal Charges in Nigeria
by Joe StephensWashington Post
May 30th, 2007
Officials in Nigeria have brought criminal charges against pharmaceutical giant Pfizer for the company's alleged role in the deaths of children who received an unapproved drug during a meningitis epidemic.

THAILAND: Holding Big Pharma's feet to the fire
by Marwaan Macan-MarkarInter Press Service
May 17th, 2007
For nearly a week, the advertising pages of Thai- and English-language dailies have been the stage for debates on Thailand's decision to break patents on anti-AIDS drugs in the interest of public health. A lobby championing the cause of the powerful pharmaceutical companies ran full-page spreads in the morning newspapers with an eye-catching warning in large, bold text, which said: "The Wrong Prescription for Thailand".

BRAZIL: Brazil to break Aids drug patent
BBC
May 4th, 2007
Brazil's president has authorised the country to bypass the patent on an Aids drug manufactured by Merck, a US pharmaceutical giant.

US: Doctors’ Ties to Drug Makers Are Put on Close View
by Gardiner HarrisThe New York Times
March 21st, 2007
Dr. Allan Collins may be the most influential kidney specialist in the country. He is president of the National Kidney Foundation and director of a government-financed research center on kidney disease.

US: BP/UC Deal Raises Concerns
by Richard BrennemanBerkeley Daily Planet
March 2nd, 2007
The proposed agreement between one of the world’s largest oil companies, BP (formerly British Petroleum) and UC Berkeley, Lawrence Berkeley National Laboratory and the University of Illinois has ignited a firestorm that promises to burn long and hot.

US: Corporate Profits Take an Offshore Vacation
by Lucy KomisarInter Press Service
February 23rd, 2007
Last week, Merck, the pharmaceutical multinational, announced that it will pay 2.3 billion dollars in back taxes, interest and penalties in one of the largest settlements for tax evasion the U.S. Internal Revenue Service (IRS) has ever imposed.

SOUTH AFRICA: MCC stalls new Aids drugs
by Belinda BeresfordMail & Guardian Online
February 3rd, 2007
South Africans have been denied the “biggest advance” in antiretroviral therapy over the last few years because of a lack of urgency in the drug registration process in South Africa, according to the Treatment Action Campaign.

INDIA: Novartis challenges India's patent law
by Matthew AllenSwiss Info
January 29th, 2007
A court case brought by Swiss drugs giant Novartis in India could define how the industry distributes discount medicine to the developing world while maintaining profits.

ASIA: Asian Govts Push Generic Drugs
by Marwaan Macan-MarkarInter Press Service
December 18th, 2006
In moves that are winning them praise, two South-east Asian governments -- in Thailand and the Philippines -- appear determined to push ahead with plans to provide cheaper generic drugs even if they incur the wrath of pharmaceutical giants.

US: Corporation wants to drill on Mt. Taylor
by Zsombor PeterThe Gallup Independent
December 7th, 2006
After drilling six exploratory holes by Mt. Taylor earlier this year in search of uranium, the Western Energy Development Corporation is asking for state and federal permission to drill 47 more.

US: Pfizer Drug Dealt Blow in Testing
by Alex BerensonThe New York Times
November 1st, 2006
Pfizer said yesterday that clinical trials of torcetrapib — a heart medication that is the most important drug in the company’s pipeline — confirmed that it raises blood pressure, a potentially serious side effect.

US: Harvard Researcher Forced Bayer to Disclose Drug Toxicity Study
by Justin Blum and Eva von SchaperBloomberg
October 6th, 2006
Bayer AG's disclosure last week of a study showing that a promising medicine has deadly side effects came only after a Harvard drug safety expert told U.S. regulators that the research existed.

US: Schering-Plough Agrees To Plead Guilty, Pay Fine
by Denise LavoieAssociated Press
August 30th, 2006
Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.

THAILAND: Patent or patient? How Washington uses trade deals to protect drugs
by Alan Beattie, Andrew Jack and Amy KazminThe Financial Times
August 22nd, 2006
As the World Health Organisation's top man in Thailand, William Aldis knew Thai officials were hosting their US counterparts in the northern city of Chiang Mai to negotiate what to many outsiders might seem an entirely worthy objective: a bi­lateral free-trade deal. But he saw dangers - and decided to make his views public.

US: Drug Companies Face Inquiry for Drug Patent
by Stephanie SaulThe New York Times
July 27th, 2006
Two big drug companies that market the best-selling drug Plavix — Sanofi-Aventis and Bristol-Myers Squibb — had been looking for good news this week: an all-clear from the federal government and several states to settle a patent dispute. Instead, they got a notice that the proposed settlement is the subject of a criminal investigation by the Department of Justice.

US: Approval of Antibiotic Worried Safety Officials
by Gardiner HarrisThe New York Times
July 19th, 2006
In an internal review, a federal drug safety official concluded that a controversial antibiotic made by a French drug company should be withdrawn, according to e-mail messages exchanged among top agency officials.

Displaying 46-65 of 161  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List »